- Home
- HOWL vs CULP Comparison
HOWL vs CULP Comparison
Compare HOWL & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- CULP
- Stock Information
- Founded
- HOWL 2017
- CULP 1972
- Country
- HOWL United States
- CULP United States
- Employees
- HOWL N/A
- CULP N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- CULP Textiles
- Sector
- HOWL Health Care
- CULP Consumer Discretionary
- Exchange
- HOWL Nasdaq
- CULP Nasdaq
- Market Cap
- HOWL 47.1M
- CULP 54.5M
- IPO Year
- HOWL 2021
- CULP N/A
- Fundamental
- Price
- HOWL $1.33
- CULP $4.06
- Analyst Decision
- HOWL Strong Buy
- CULP
- Analyst Count
- HOWL 3
- CULP 0
- Target Price
- HOWL $8.33
- CULP N/A
- AVG Volume (30 Days)
- HOWL 199.3K
- CULP 16.2K
- Earning Date
- HOWL 08-14-2025
- CULP 09-03-2025
- Dividend Yield
- HOWL N/A
- CULP N/A
- EPS Growth
- HOWL N/A
- CULP N/A
- EPS
- HOWL N/A
- CULP N/A
- Revenue
- HOWL N/A
- CULP $213,237,000.00
- Revenue This Year
- HOWL N/A
- CULP $2.41
- Revenue Next Year
- HOWL N/A
- CULP $3.46
- P/E Ratio
- HOWL N/A
- CULP N/A
- Revenue Growth
- HOWL N/A
- CULP N/A
- 52 Week Low
- HOWL $0.60
- CULP $3.42
- 52 Week High
- HOWL $4.18
- CULP $6.85
- Technical
- Relative Strength Index (RSI)
- HOWL 58.20
- CULP 36.90
- Support Level
- HOWL $1.12
- CULP $3.99
- Resistance Level
- HOWL $1.29
- CULP $4.41
- Average True Range (ATR)
- HOWL 0.08
- CULP 0.16
- MACD
- HOWL 0.01
- CULP -0.04
- Stochastic Oscillator
- HOWL 75.00
- CULP 14.89
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About CULP Culp Inc.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.